MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Nephros Operating Expenses 2011-2026 | NEPH
Annual Operating Expenses Nephros
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.5 M | 8.72 M | 10 M | 9.07 M | 8.88 M | 9.42 M | 9.24 M | 6.22 M | 4.52 M | 4.16 M | 4.48 M | 3.87 M | 4.16 M | 4.4 M | 3.18 M | 3.01 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.5 M | 3.01 M | 6.49 M |
Quarterly Operating Expenses Nephros
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.9 M | 2.6 M | 2.55 M | 2.59 M | - | 1.94 M | 2.23 M | 2.39 M | - | 2.4 M | 2.51 M | 2.42 M | - | 2.04 M | 2.21 M | 2.6 M | - | 2.16 M | 2.39 M | 2.6 M | - | 2.16 M | 2.49 M | 2.52 M | - | 2.51 M | 2.24 M | 2.3 M | - | 1.46 M | 1.48 M | 1.59 M | - | 1.05 M | 1.22 M | 1.06 M | - | 953 K | 1.11 M | 1.1 M | - | 1.25 M | 952 K | 1.09 M | - | 997 K | 935 K | 929 K | - | 837 K | 977 K | 1.33 M | - | 1.27 M | 1.08 M | 867 K | - | 734 K | 801 K | 845 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.9 M | 734 K | 1.71 M |
Operating Expenses of other stocks in the Medical instruments industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
1.23 B | $ 59.78 | -0.99 % | $ 11.9 B |  USA |
 |
Atrion Corporation
ATRI
|
39.8 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
iRhythm Technologies
IRTC
|
585 M | $ 114.31 | 0.13 % | $ 3.66 B | USA |
 |
ICU Medical
ICUI
|
779 M | $ 119.39 | -2.93 % | $ 2.94 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
7.99 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
3.7 B | $ 421.75 | -1.47 % | $ 151 B | USA |
 |
Repro Med Systems
KRMD
|
28.6 M | $ 3.93 | -1.26 % | $ 182 M | USA |
 |
Alcon
ALC
|
3.37 B | $ 63.78 | -0.34 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
111 M | $ 97.38 | -2.13 % | $ 2.2 B | USA |
 |
Masimo Corporation
MASI
|
1.27 B | $ 178.49 | 0.08 % | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
72.9 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
388 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
20.2 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.27 B | $ 23.4 | -1.89 % | $ 3.93 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.05 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
40.9 M | $ 6.04 | -6.07 % | $ 51.2 K | USA |
 |
Haemonetics Corporation
HAE
|
527 M | $ 56.73 | -0.68 % | $ 2.86 B | USA |
 |
Isoray
ISR
|
114 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
368 M | $ 143.49 | 0.93 % | $ 6.95 B | USA |
 |
STAAR Surgical Company
STAA
|
100 M | $ 32.41 | 1.25 % | $ 1.61 B | USA |
 |
STERIS plc
STE
|
1.54 B | $ 211.83 | -1.92 % | $ 20.9 B | USA |
 |
Teleflex Incorporated
TFX
|
1.05 B | $ 130.52 | 0.18 % | $ 5.82 B | USA |
 |
InfuSystem Holdings
INFU
|
68.4 M | $ 8.65 | 0.46 % | $ 179 M | USA |
 |
Microbot Medical
MBOT
|
9.09 K | $ 1.88 | 1.35 % | $ 86.1 M |  Israel |
 |
Milestone Scientific
MLSS
|
12.1 M | $ 0.33 | -2.77 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
554 M | $ 61.59 | -1.55 % | $ 3.64 B | USA |
 |
Utah Medical Products
UTMD
|
11.8 M | $ 63.27 | -0.68 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
301 M | $ 303.95 | 1.25 % | $ 22 B | USA |
 |
Pulse Biosciences
PLSE
|
48 M | $ 24.33 | -10.22 % | $ 1.64 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.72 B | $ 9.99 | -3.99 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
21.2 M | $ 0.65 | -5.8 % | $ 19.5 M | USA |
 |
Pro-Dex
PDEX
|
8.82 M | $ 59.75 | 1.88 % | $ 196 M | USA |
 |
Predictive Oncology
POAI
|
13.1 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
17.8 M | $ 20.35 | -3.4 % | $ 972 M | USA |
 |
Stereotaxis
STXS
|
39.2 M | $ 1.89 | -3.08 % | $ 172 M | USA |
 |
Baxter International
BAX
|
3.88 B | $ 17.34 | -2.47 % | $ 8.9 B | USA |
 |
ResMed
RMD
|
1.02 B | $ 202.44 | -0.01 % | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
410 M | $ 28.16 | 0.04 % | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
98.5 M | $ 5.37 | -2.72 % | $ 238 M | USA |
 |
NeuroMetrix
NURO
|
10.5 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
198 M | $ 10.79 | -2.18 % | $ 441 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.05 B | $ 143.35 | -0.77 % | $ 41.2 B | USA |
 |
OraSure Technologies
OSUR
|
120 M | $ 3.07 | 3.9 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
115 M | $ 103.63 | 0.24 % | $ 5.83 M | USA |